Preoperative staging of rectal cancer allows selection of patients for preoperative radiotherapy

被引:19
作者
Horgan, AF [1 ]
Finlay, IG [1 ]
机构
[1] Glasgow Royal Infirm, Dept Coloproctol, Glasgow G31 2ER, Lanark, Scotland
关键词
D O I
10.1046/j.1365-2168.2000.01396.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Variability in rates of local recurrence following resection of rectal cancer has led to the suggestion that all patients should undergo preoperative radiotherapy. This centre employs a selective policy of radiotherapy only in patients with evidence of advanced local disease determined by preoperative staging. Methods: A retrospective review was carried out of 114 consecutive patients with rectal cancer. Patients were divided before operation into palliative and curative,groups based on preoperative staging. Only patients in the palliative group were offered preoperative radiotherapy. Total mesorectal excision (TME) was performed for all tumours of the middle or lower rectum. Results: The perioperative mortality rate was 0.9 per cent and anastomotic dehiscence occurred in 2.8 per cent. Local recurrence developed in 4 per cent of patients in the 'curative' group and in seven of 15 of those assigned to the palliative group before operation (P < 0.01). Positive lateral resection margins were significantly associated with a risk of subsequent recurrence (ten of 13 versus three (3 per cent) of 93; P < 0.001). Conclusion: Preoperative adjuvant radiotherapy can be omitted reasonably in patients in whom there is no evidence of locally advanced disease, provided that adequate surgery, incorporating TME for low tumours, is performed.
引用
收藏
页码:575 / 579
页数:5
相关论文
共 25 条
[1]   RECURRENCE RATES AFTER CURATIVE SURGERY FOR RECTAL-CARCINOMA, WITH SPECIAL REFERENCE TO THEIR ACCURACY [J].
CARLSSON, U ;
LASSON, A ;
EKELUND, G .
DISEASES OF THE COLON & RECTUM, 1987, 30 (06) :431-434
[2]   EXTENT OF MESORECTAL SPREAD AND INVOLVEMENT OF LATERAL RESECTION MARGIN AS PROGNOSTIC FACTORS AFTER SURGERY FOR RECTAL-CANCER [J].
CAWTHORN, SJ ;
PARUMS, DV ;
GIBBS, NM ;
AHERN, RP ;
CAFFAREY, SM ;
BROUGHTON, CIM ;
MARKS, CG .
LANCET, 1990, 335 (8697) :1055-1059
[3]   CARCINOMA OF THE RECTUM - A 10-YEAR EXPERIENCE [J].
DIXON, AR ;
MAXWELL, WA ;
HOLMES, JT .
BRITISH JOURNAL OF SURGERY, 1991, 78 (03) :308-311
[4]  
ENKER WE, 1995, J AM COLL SURGEONS, V181, P335
[5]   POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01 [J].
FISHER, B ;
WOLMARK, N ;
ROCKETTE, H ;
REDMOND, C ;
DEUTSCH, M ;
WICKERHAM, DL ;
FISHER, ER ;
CAPLAN, R ;
JONES, J ;
LERNER, H ;
GORDON, P ;
FELDMAN, M ;
CRUZ, A ;
LEGAULTPOISSON, S ;
WEXLER, M ;
LAWRENCE, W ;
ROBIDOUX, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01) :21-29
[6]   LOCAL RECURRENCE OF CARCINOMA OF COLON AND RECTUM [J].
FLOYD, CE ;
CORLEY, RG ;
COHN, I .
AMERICAN JOURNAL OF SURGERY, 1965, 109 (02) :153-&
[7]  
GALANDIUK S, 1992, SURG GYNECOL OBSTET, V174, P27
[8]   PREOPERATIVE RADIOTHERAPY AS ADJUVANT TREATMENT IN RECTAL-CANCER - FINAL RESULTS OF A RANDOMIZED STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER (EORTC) [J].
GERARD, A ;
BUYSE, M ;
NORDLINGER, B ;
LOYGUE, J ;
PENE, F ;
KEMPF, P ;
BOSSET, JF ;
GIGNOUX, M ;
ARNAUD, JP ;
DESAIVE, C ;
DUEZ, N .
ANNALS OF SURGERY, 1988, 208 (05) :606-614
[9]  
GILBERTSEN VA, 1962, SURG GYNECOL OBSTET, V114, P313
[10]  
HEALD RJ, 1986, LANCET, V1, P1479